Expanded Quantitative Urinary Culture (EQUC) vs Standard Culture (SUC) Techniques in the Clinical Care
The Use of Expanded Quantitative Urinary Culture (EQUC) Versus Standard Culture (SUC) Techniques in the Clinical Care of Women With Symptoms of Urinary Tract Infections.
1 other identifier
interventional
225
1 country
1
Brief Summary
This purpose of this study is to see if expanded urine culture techniques used in the laboratory improve the clinical care of women over standard urine culture techniques.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 14, 2017
CompletedStudy Start
First participant enrolled
June 15, 2017
CompletedFirst Posted
Study publicly available on registry
June 16, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2020
CompletedJune 16, 2020
June 1, 2020
2.8 years
June 14, 2017
June 11, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Compare UTI symptom resolution rates in women with symptoms of UTI who are treated based on EQUC versus SUC results.
Using the FPMRS treatment algorithms (see appendix I \& II Standard Urine Culture Treatment and Expanded Urine Culture Treatment Algorithms), attending physicians will treat participants based on their randomization to EQUC versus SUC. Following a 3-5 day standard course of treatment (which may include no antibiotics if the culture is negative), participants will be queried 7-10 days "do you continue to have UTI symptoms". Women who report "no" will be categorized as successful treatment, women who respond "yes" will be categorized as treatment failures.
4 weeks
Secondary Outcomes (2)
Revise the EQUC treatment algorithm.
6 months
Identify the symptom profile associated with specific organisms.
1 year
Study Arms (2)
Expanded Urinary Culture (EQUC)
EXPERIMENTALParticipants in this arm will receive the expanded urine culture
Standard Urine Culture (SUC)
ACTIVE COMPARATORParticipants in this arm will receive the standard urine culture
Interventions
involves the inoculation of 100X (0.1mL) more urine onto diverse types of media (BAP, chocolate agar, colistin and nalidixic acid (CNA) agar, CDC anaerobe 5% BAP) with incubation in more environments and temperatures (5% CO2 at 35°C for 48 h, aerobic conditions at 35°C and 30°C for 48 h, Campy gas mixture (5% O2, 10% CO2, 85% N) or anaerobic conditions at 35°C for 48 h). The level of detection for EQUC is 10 CFU/mL, represented by 1 colony of growth on any of the plates. EQUC is designed to isolate a broad array of Gram-negative and Gram-positive bacteria, including anaerobes and fastidious bacteria that grow slowly.
involves inoculation of 0.001 mL of urine onto 5% sheep blood agar plate (BAP) and MacConkey agar plate with the plates being incubated aerobically at 35°C for 24 h. Thus, the level of detection for standard culture is 103 CFU/mL, represented by 1 colony of growth on either plate. Standard culture is designed specifically to grow Gram-negative rods, especially UPEC.
Eligibility Criteria
You may qualify if:
- A "yes" answer to the screening question "do you feel you have a UTI"?
- Non-pregnant women ages 18 years or older
- Agreement to respond to a text or email question 7-10 days after treatment plan for their UTI (note: the treatment plan may include "no treatment").
You may not qualify if:
- Women currently on antibiotics
- Patients who cannot communicate or read in English
- Patients under the age of 18
- Pregnant patients
- Women with an indwelling catheter and intermittent self-catheterization
- Men
- Urine obtained via the "clean catch method" (i.e. voided urine)
- Women who refuse to be catheterized
- Women who cannot or will not agree to respond to an email or text message 7-10 days after treatment plan is initiated.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Loyola University Medical Center
Maywood, Illinois, 60153, United States
Related Publications (3)
KASS EH. Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians. 1956;69:56-64. No abstract available.
PMID: 13380946RESULTMaskell R, Pead L, Allen J. The puzzle of "urethral syndrome": a possible answer? Lancet. 1979 May 19;1(8125):1058-9. doi: 10.1016/s0140-6736(79)92953-2.
PMID: 86778RESULTYuan S, Cohen DB, Ravel J, Abdo Z, Forney LJ. Evaluation of methods for the extraction and purification of DNA from the human microbiome. PLoS One. 2012;7(3):e33865. doi: 10.1371/journal.pone.0033865. Epub 2012 Mar 23.
PMID: 22457796RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elizabeth Mueller, MD
Loyola University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D., Professor
Study Record Dates
First Submitted
June 14, 2017
First Posted
June 16, 2017
Study Start
June 15, 2017
Primary Completion
March 30, 2020
Study Completion
April 30, 2020
Last Updated
June 16, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share